Showing results (1-10 of 5,921) with videos related to
Sort By:
Pageof 593
Journal of Immunological Methods|November 18, 1998
Immunodetection and characterisation of soluble CD105-TGFbeta complexesC G Li, P B Wilson, C Bernabeu, et al.Atherosclerosis|February 1, 1996
Serum levels of the TGF-beta receptor are increased in atherosclerosisA D Blann, J M Wang, P B Wilson, et al.Journal of Immunological Methods|May 2, 1994
Quantitation of endothelial cell specific protein E-9 employing a single monoclonal antibody in an indirect sandwich ELISAJ M Wang, P B Wilson, S Kumar, et al.The Journal of Biological Chemistry|November 26, 1998
Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycanA Letamendía, P Lastres, L M Botella, et al.FEBS Letters|August 18, 1997
The use of recombinant vaccinia virus to generate monoclonal antibodies against the cell-surface glycoprotein endoglinA Luque, C Cabañas, U Raab, et al.Atherosclerosis|September 21, 2000
The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery diseaseC G Li, H Bethell, P B Wilson, et al.Microscopy Research and Technique|February 15, 2001
Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105C Li, B Guo, C Bernabeu, et al.Oncology|January 1, 1982
Increased incidence of antibody in pre-malignant occupational bladder cancerS Kumar, P B Wilson, C B CostelloInternational Journal of Cancer|May 20, 1998
Endoglin, a component of the TGF-beta receptor system, is a differentiation marker of human choriocarcinoma cellsA Letamendía, P Lastres, N Almendro, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 8, 2000
CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cellsC Li, I N Hampson, L Hampson, et al.Pageof 593